Get started
Author

Jean François Yale

Observed names: J F Yale, JEAN FRANCOIS YALE, JF Yale, Jean F. Yale, Jean Francois Yale, Jean- Francois Yale
OpenAlex ID: A5111898715
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
2014 · Vasilios Papademetriou, Laura Lovato, et al. · Kidney International · 211
Association of Depression With Accelerated Cognitive Decline Among Patients With Type 2 Diabetes in the ACCORD-MIND Trial
2013 · Mark D. Sullivan, Wayne J. Katon, et al. · JAMA Psychiatry · 135
PDF
Problems in transition from pediatric care to adult care for individuals with diabetes
2005 · Danièle Pacaud, Jean François Yale, et al. · Canadian Journal of Diabetes · 118
Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment.
1988 · J F Yale, M Chamelian, et al. · PubMed · 31
Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.
2000 · J K Malone, H Yang, et al. · PubMed · 23
Performance de glicosímetro utilizado no automonitoramento glicêmico de portadores de diabetes mellitus tipo 1
2006 · Giane Sprada Mira, Lys Mary Bileski Candido, et al. · Arquivos Brasileiros de Endocrinologia & Metabologia · 18
PDF
Effect of an intervention to improve the management of patients with diabetes in primary care practice.
2011 · Assim A. Alfadda, Khalid A. Bin-Abdulrahman, et al. · Saudi Medical Journal · 16
Is silent myocardial infarction more common in women with type 2 diabetes than in men?
2012 · Monica C. Stiles, Elizabeth R. Seaquist, et al. · Journal of Diabetes and its Complications · 15
Insulin-plus-Pramlintide Artificial Pancreas in Type 1 Diabetes—Randomized Controlled Trial
2018 · AHMAD HAIDAR, MICHAEL TSOUKAS, et al. · Diabetes · 10
1679-P: Current State of Type 1 Diabetes in Adults: Data from the Canadian LMC Diabetes Registry
2019 · RONNIE ARONSON, RUTH E. BROWN, et al. · Diabetes · 1
Author response for "Use of once‐weekly semaglutide in patients with type 2 diabetes in routine clinical practice: results from the SURE Canada multicenter, prospective, observational study"
2021 · JF Yale, AM Catarig, et al. · Publons reviews and discussion
Hypoglykämierisiko und C-Peptid-Konzentrationen bei Menschen mit Typ-2-Diabetes und Therapie mit Insulin glargin 300 E/ml (Gla-300) oder Insulin glargin 100 E/ml (Gla-100)
2018 · R Ritzel, G Bolli, et al. · Diabetologie und Stoffwechsel
Hypoglykämie als Funktion des HbA1c bei Typ-2-Diabetes mellitus (T2DM): Insulin glargin 300 E/ml in einer Metaanalyse auf Patientenebene der Studien EDITION 1, 2 und 3
2017 · RC Bonadonna, JF Yale, et al. · Diabetologie und Stoffwechsel
Ältere Menschen mit Typ-2-Diabetes: Glykämische Kontrolle und Hypoglykämierisiko mit dem neuen Insulin Glargin 300 E/ml
2016 · R Ritzel, JF Yale, et al. · Diabetologie und Stoffwechsel
Factors Associated with Hospital Admissions Due to Hypoglycemia Events in Canada
2012 · Irene Hramiak, Lawrence A. Leiter, et al. · Canadian Journal of Diabetes
Glycemia Management in Family Practice in Canada - Preliminary Results of a Chart Audit from AIM@GP
2008 · Stewart Harris, Hertzel Gerstein, et al. · Canadian Journal of Diabetes
Pdb57 Treatment Satisfaction and Quality of Life With an Early Insulinization Strategywith Insulin Glargine Compared to an Adjusted Oral Therapy in the Management of Type-2 Diabetes: the Canadian Insight Study
2005 · R Houlden, S Harris, et al. · Value in Health
Preface
2004 · Brian M. Frier, Jean Francois Yale · Diabetes Research and Clinical Practice
Works count: 18
Citation count: 578
H-index: 9
I10-index: 9
Year
Topic
Type